Regulation of ARF tumor suppressor function by biological phase separation

通过生物相分离调节ARF肿瘤抑制功能

基本信息

  • 批准号:
    10065965
  • 负责人:
  • 金额:
    $ 6.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-09 至 2021-07-08
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The proposed study aims to determine how phase separation regulates the ARF protein, a tumor suppressor that frequently experiences loss of function in human cancers. During oncogenic stress, ARF sequesters essential proteins in the nucleolus in order to arrest the cell cycle or induce apoptosis. Specifically, ARF sequesters HDM2 in the nucleolus, which activates p53-dependent cell cycle arrest or apoptosis. ARF also sequesters NPM1 in the nucleolus, disrupting ribosome assembly, which also induces cell cycle arrest independently of p53. However, the mechanism by which ARF sequesters its targets in the nucleolus is not understood. Recent observations have demonstrated that nucleoli possess liquid-like properties, which manifest through phase separation of their constituent proteins and RNAs. Recently, our lab along with the Brangwynne group, showed that the liquid like features of the nucleolus depends in-part on the phase separation properties of NPM1. I hypothesize that p14ARF disrupts the liquid-like properties of the granular component through hydrophobic self-association and multivalent interactions of its multiple arginine-rich motifs with NPM1, resulting in inhibition of ribosome biogenesis. This study will determine (1) how p14ARF’s physicochemical properties allow it to sequester its target proteins within phase separated bodies, (2) the structure and dynamics of phase separated p14ARF-NPM1 complexes, and (3) the effect of p14ARF expression on NPM1 dynamics, ribosome biogenesis and growth in live cells. Results from this study will provide novel insights into ARF’s nucleolar tumor suppressor function, and in a broader context, how the fluid-features of nucleoli are altered during oncogenic stress events.
项目摘要 这项研究的目的是确定相分离如何调节肿瘤抑制因子ARF蛋白 在人类癌症中经常发生功能丧失。在致癌应激期间, 在核仁中的必需蛋白质,以阻止细胞周期或诱导凋亡。具体而言,ARF 将HDM 2隔离在核仁中,其激活p53依赖性细胞周期停滞或凋亡。ARF还 将NPM 1隔离在核仁中,破坏核糖体组装,这也诱导细胞周期停滞 与p53无关。然而,ARF将其靶点隔离在核仁中的机制并不明确。 明白 最近的观察表明,核仁具有类似液体的性质,这表现在 其组成蛋白质和RNA的相分离。最近,我们的实验室沿着与布兰温集团, 表明核仁的液体状特征部分取决于NPM 1的相分离性质。 我假设p14 ARF通过以下途径破坏了颗粒组分的液体样性质: 其多个富含甘氨酸的基序与NPM 1的疏水自缔合和多价相互作用, 导致核糖体生物合成的抑制。 本研究将确定(1)p14 ARF的物理化学性质如何使其能够螯合其靶点 (2)相分离的p14 ARF-NPM 1的结构和动力学 p14 ARF表达对NPM 1动力学、核糖体生物合成和生长的影响 在活细胞中。这项研究的结果将为ARF的核仁肿瘤抑制功能提供新的见解, 以及在更广泛的背景下,在致癌应激事件期间,核仁的流体特征如何改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric B Gibbs其他文献

Eric B Gibbs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Cerebral infarction treatment strategy using collagen-like "triple helix peptide" containing functional amino acid sequence
含功能氨基酸序列的类胶原“三螺旋肽”治疗脑梗塞策略
  • 批准号:
    23K06972
  • 财政年份:
    2023
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a screening method for functional microproteins independent of amino acid sequence conservation
不依赖氨基酸序列保守性的功能性微生物蛋白筛选方法的建立
  • 批准号:
    23KJ0939
  • 财政年份:
    2023
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Effects of amino acid sequence and lipids on the structure and self-association of transmembrane helices
氨基酸序列和脂质对跨膜螺旋结构和自缔合的影响
  • 批准号:
    19K07013
  • 财政年份:
    2019
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of electron-transfer amino acid sequence probe with an interaction for protein and cell
蛋白质与细胞相互作用的电子转移氨基酸序列探针的构建
  • 批准号:
    16K05820
  • 财政年份:
    2016
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of artificial antibody of anti-bitter taste receptor using random amino acid sequence library
利用随机氨基酸序列库开发抗苦味受体人工抗体
  • 批准号:
    16K08426
  • 财政年份:
    2016
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The aa15-17 amino acid sequence in the terminal protein domain of HBV polymerase as a viral factor affect-ing in vivo as well as in vitro replication activity of the virus.
HBV聚合酶末端蛋白结构域中的aa15-17氨基酸序列作为影响病毒体内和体外复制活性的病毒因子。
  • 批准号:
    25461010
  • 财政年份:
    2013
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Amino acid sequence analysis of fossil proteins using mass spectrometry
使用质谱法分析化石蛋白质的氨基酸序列
  • 批准号:
    23654177
  • 财政年份:
    2011
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Precise hybrid synthesis of glycoprotein through amino acid sequence-specific introduction of oligosaccharide followed by enzymatic transglycosylation reaction
通过氨基酸序列特异性引入寡糖,然后进行酶促糖基转移反应,精确杂合合成糖蛋白
  • 批准号:
    22550105
  • 财政年份:
    2010
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimating selection on amino-acid sequence polymorphisms in Drosophila
果蝇氨基酸序列多态性选择的估计
  • 批准号:
    NE/D00232X/1
  • 财政年份:
    2006
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Research Grant
Construction of a neural network for detecting novel domains from amino acid sequence information only
构建仅从氨基酸序列信息检测新结构域的神经网络
  • 批准号:
    16500189
  • 财政年份:
    2004
  • 资助金额:
    $ 6.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了